The board of VISEN PHARMA-B (02561) has announced the appointment of three new non-executive directors.
Following approval by shareholders at the annual general meeting, the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass, and Mr. Michael J. Chang have taken effect.
Their appointments as non-executive directors became effective from June 26, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments